quot;nType 1 Diabetes Mellitus in most cases is an autoimmune disease. Insulin injection is just a symptom therapy that is bothering for the patient and usually does not correct the blood glucose level appropriately. Attempts to replace the lost pancreatic cells such as islet and stem cell ...
Mesenchymal stem cell-based therapy for the treatment of type 1 diabetes mellitus. Curr Stem Cell Res Ther 2012;7:179-90... M Mabed,M Shahin - 《Current Stem Cell Research & Therapy》 被引量: 61发表: 2012年 Mesenchymal stem cell-based therapy for the treatment of type 1 diabetes mellit...
摘要: Use of a growth hormone antagonist to reduce the overnight insulin requirement of a patient suffering from Type I diabetes mellitus or from dawn phenomenon.收藏 引用 批量引用 报错 分享 文库来源 求助全文 Treatment of type i diabetes mellitus 优质文献 ...
1 diabetes mellitus Thymogen in the treatment of type-1 diabetes mellitusThymogen in the treatment of type-1 diabetes mellitusPostnikov, A AModel, S VBozh'ev, A AAtopkov, V ATsyba, N NGalkin, I V
简要标题 Family-Based Treatment for Type 1 Diabetes 临床分期 N/A 招募状态 Recruiting 首次公开日期 2023-03-06 条件/疾病 Diabetes Mellitus, Type 1 | Obesity, Childhood | Comorbidities and Coexisting Conditions | Overweight 干预/治疗 Family-Based Treatment for T1D 申办方 State University of New Yor...
With type 1 diabetes, you may also experience nausea, vomiting, or stomach pains.3 Causes and Risk Factors Researchers don't know the exact cause of diabetes mellitus. Type 1 is believed to be caused by an overactive immune reaction that mistakenly attacks the pancreas. The following puts you...
CD4(+) T cell-dominant insulitis in acute-onset Type 1 diabetes mellitus associated with intraductal papillary mucinous adenoma The loss of insulin-producing pancreatic beta-cells in Type 1 diabetes mellitus (DM) is presumably the result of a T cell. mediated process. In general, CD... Yajima...
OtelixizumabTeplizumabType 1 diabetes mellitusAnti-CD3 therapy preserves stimulated C-peptide/insulin across trials and molecules.A brief treatment has >2... AG Daifotis,S Koenig,L Chatenoud,... - 《Clinical Immunology》 被引量: 113发表: 2013年 Efficacy and safety of low-dose otelixizuma...
TIANJIN, June 5 (Xinhua) -- Chinese researchers have achieved a breakthrough in developing a new type of hydrogel material for type 1 diabetes mellitus (T1DM) treatment, according to a research team from Tianjin University. Islets can be coated with the new hydrogel which can serve as an exc...
Insulin allows glucose to move out of the blood into cells throughout the body, where it is used for fuel. People with diabetes mellitus either do not produce enough insulin (type 1 diabetes), cannot use insulin properly (type 2 diabetes), or both (various forms of diabetes). In diabetic...